Most Members of Federal Fetal Tissue Ethics Panel Oppose Abortion

The members of a new advisory board to the NIH met for the first time and will weigh in on federal funding for grants that rely on donated tissue from abortions.

Written byLisa Winter
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM, BLACKHOLY

Update (August 19): The panel has rejected 13 of the 14 proposals it has considered thus far, The Washington Post reports.

More than a year after the Department of Health and Human Services announced the creation of the National Institutes of Health Human Fetal Tissue Research Ethics Advisory Board, members of the committee convened for the first time on Friday (July 31) to oversee the ethics of using fetal tissue in federally funded research. Of the 15 committee members, appointed by President Donald Trump, 10 have a history of activism against abortion or fetal tissue use. As Buzzfeed News reports, some researchers have voiced concerns that the panel could impair future research on HIV, diabetes, COVID-19 vaccines, and more.

The board’s purpose is to review research grant proposals that study human fetal tissue (HFT) and advise that they receive funding only if no adequate alternatives exist ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies